The US Food and Drug Administration (FDA) has released information on what it calls its flexible approach to overseeing ...
US biotech Moderna today announced business updates and progress across its pipeline of mRNA medicines. Moderna enters 2026 ...
US biopharma Eikon Therapeutics plans to go public via an IPO on the Nasdaq, following in the footsteps of Aktis ...
Swiss biotech startup FluoSphera has raised 1.23 million euros ($1.34 million) to expand commercial activity and advance its ...
US radiopharma newcomer Aktis Oncology (Nasdaq: AKTS) raised about $318 million after pricing an upsized initial public ...
Europe is in danger of falling behind in the development of innovative medicines, according to Dutch pharma trade group VIG ...
US pharma giant Pfizer on Saturday announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...
Royalty Pharma and the US affiliate of Israel’s Teva Pharmaceutical Industries have announced a funding agreement of up to ...
San Francisco, USA-based Chai Discovery, the AI company building a computer-aided design suite for molecules, has announced a ...
US biotech start-up Aurora Therapeutics has launched with $16 million in seed funding from Menlo Ventures, aiming to turn one ...
Swiss pharma trade body Interpharma has warned that Switzerland’s position as a global pharmaceutical hub is under strain ...
German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback